2 ms·
Yes. How is this so hard to comprehend? I don't care how much a drug costs and nobody should. The reason we pay for insurance is to use it when we need it. Sam
by avgDev 4y ago
Yes. How is this so hard to comprehend?
I don't care how much a drug costs and nobody should. The reason we pay for insurance is to use it when we need it. Same goes for disability insurance. All these insurance companies will do anything possible to weasel out of paying.
I don't know a single person happy with health insurance companies that has used them extensively.
If there is a case study that shows a certain drug resolved symptoms that a physician's patient is suffering from, he should be allowed to prescribe them off-label.
US spends 18/% of GDP on healthcare, and we still have to pay into the insurance scam. I would at least expect to get the best care in the world and access to any medication my physicians desires without any bullshit.
- twoodfin 4y agoIf anyone with an MD can prescribe any medicine with any rationale, and biologics stay at these 6-figure costs, you will certainly see more than 18% of US GDP being spent on healthcare.
- avgDev 4y agoHow? The US govt. won't be paying the bill in most cases.
- ceejayoz 4y agoThat's still counted in GDP.
- runako 4y ago> and biologics stay at these 6-figure costs High healthcare cost is the entire reason we pay for health insurance. If treatments were cheaper, UNH would not be worth half a trillion dollars. Put another way, this is exactly what UNH signed up for. They actively lobby against efforts to reduce healthcare costs at the expense of their profits, which largely derive from amortizing the risk that some of their customers will have treatments too expensive for them to afford. As an analogy, a home insurer doesn't get sympathy when they try to dodge rebuilding costs after a fire or other disaster reduces their profits. The insurer explicitly signed up for the job of paying for the rebuilds, and that was not contingent on the cost of the hypothetical future rebuilds. They have the scale to influence healthcare costs through means other than denying claims. And they have the financial heft to (for example) buy makers of expensive niche treatments if they dislike other market participants capturing healthcare dollars. TL;DR; this is a problem entirely of UNH's own making, for which they are well compensated by the markets. Regulators should not allow them to operate in our regulated markets in this manner.
- mr_woozy 4y ago[dead]